These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1232993)

  • 1. [Dialysis of methylguanidine and hypothesis on the middle molecules].
    Barsotti G; Giovannetti S
    Ateneo Parmense Acta Biomed; 1975; 46(5):317-30. PubMed ID: 1232993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Removal by dialysis of methylguanidine from body fluids.
    Barsotti G; Giovannetti S
    Proc Eur Dial Transplant Assoc; 1975; 11():105-11. PubMed ID: 1197242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis. Correlations between nerve conduction velocities and altered guanidino compound concentrations.
    De Deyn PP; Robitaille P; Vanasse M; Qureshi IA; Marescau B
    Nephron; 1995; 69(4):411-7. PubMed ID: 7777105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Methylguanidine dialysis and the hypothesis of the mean molecules].
    Barsotti G; Rindi P
    Minerva Nefrol; 1974; 21(4):270-4. PubMed ID: 4467048
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of hemodialysis on serum guanidine and methylguanidine levels.
    Perez G; Santos B
    Proc Clin Dial Transplant Forum; 1973; 3():110-3. PubMed ID: 4806625
    [No Abstract]   [Full Text] [Related]  

  • 6. Dialysis of methylguanidine.
    Giovannetti S; Barsotti G
    Kidney Int; 1974 Sep; 6(3):177-83. PubMed ID: 4425483
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of hemodialysis on endogenous middle molecules in uremic patients.
    Asaba H; Fürst P; Oulés R; Yahiel V; Zimmerman L; Bergström J
    Clin Nephrol; 1979 May; 11(5):257-66. PubMed ID: 455822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of recombinant human erythropoietin on synthesis of methylguanidine in uraemic patients on haemodialysis or continuous ambulatory peritoneal dialysis.
    Sasagawa I; Nakada T; Kubota Y; Sawamura T; Suzuki H; Hashimoto T
    Int Urol Nephrol; 1994; 26(6):701-5. PubMed ID: 7759207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A selective method for determination of methylguanidine in biological fluids. Its application in normal subjects and uremic patients.
    Eksborg S; Persson BA; Allgen LG; Bergström J; Zimmerman L; Fürst P
    Clin Chim Acta; 1978 Jan; 82(1-2):141-50. PubMed ID: 618677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylguanidine and insulin response in patients on maintenance haemodialysis.
    Ferrannini E; Navalesi R; Pilo A; Morelli E
    Lancet; 1976 Nov; 2(7993):1028-9. PubMed ID: 62253
    [No Abstract]   [Full Text] [Related]  

  • 11. Rethinking the peritoneal dialysis prescription: results of recent studies.
    Bargman JM
    Nephrology (Carlton); 2006 Apr; 11(2):85-9. PubMed ID: 16669966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrectomy and peritoneal dialysis eliminates circulating renin and controls uraemia in the rat.
    Pedersen TF; Nielsen AH; Strandgaard S; Paulson OB
    J Renin Angiotensin Aldosterone Syst; 2002 Jun; 3(2):130-4. PubMed ID: 12228855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What we have learned about uremia from peritoneal dialysis.
    Nolph KD
    ASAIO J; 1992; 38(4):745-50. PubMed ID: 1450467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperlipidemia in uremic children: response to peritoneal dialysis and hemodialysis.
    Berger M; James GP; Davis ER; Jasper PM; Brouhard BH; Travis LB; Cunningham RJ
    Clin Nephrol; 1978 Jan; 9(1):19-24. PubMed ID: 343952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acid-base equilibrium in uremia: effect of continuous ambulatory peritoneal dialysis and hemodialysis].
    Nin Ferrari J; Santoro A; Fabbri L; Cavilli F; Zucchelli P
    G Clin Med; 1981 Sep; 62(9):624-33. PubMed ID: 7319174
    [No Abstract]   [Full Text] [Related]  

  • 16. Guanidino compounds in uraemic dialysed patients.
    De Deyn P; Marescau B; Lornoy W; Becaus I; Lowenthal A
    Clin Chim Acta; 1986 Jun; 157(2):143-50. PubMed ID: 3719996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hemodialysis on guanidinopropionic acid metabolism.
    Gurreri G; Ghiggeri G; Salvidio G; Garibotto G; Robaudo C; Deferrari G
    Nephron; 1986; 42(4):295-7. PubMed ID: 3960241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum guanidino compound levels and clearances in uremic patients treated with continuous ambulatory peritoneal dialysis.
    De Deyn PP; Marescau B; Swartz RD; Hogaerth R; Possemiers I; Lowenthal A
    Nephron; 1990; 54(4):307-12. PubMed ID: 2325795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical analytic approaches to the definition of uremic toxins.
    Furst P; Bergstrom J; Gordon A; Zimmermann L
    Ateneo Parmense Acta Biomed; 1975; 46(5):307-16. PubMed ID: 1232992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on guanidine compounds in uremia: reevaluation of serum GSA in relation to acute symptoms of uremia (author's transl)].
    Tofuku Y; Kuroda M; Kita T; Takeda R
    Nihon Jinzo Gakkai Shi; 1980 Mar; 22(3):249-58. PubMed ID: 7382166
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.